Cell Therapy Hits a Stumbling Block

Cell therapy is a fascinating approach to treat hemophilia. But recently the clinical trials hit a stumbling block. What happened? Read more from Paul Clement, science writer for the hemophilia community.

Source: Hemablog, The Communique’, February 2022

Paul Clement is a science writer for the hemophilia community who enjoyed a long career as a high school science teacher. He is especially adept at translating complex topics into easy-to-understand language. He is the chief science writer and editor for LA Kelley Communications’ publications, including the Parent Empowerment Newsletter from 1998-2021 and PEN’s Insurance Pulse magazine from 2009-2020. He is co-author of the books Managing Your Child’s Inhibitor and A Guide to Living with von Willebrand Disease. He holds a bachelor’s degree in biology and a master’s degree in science education from California State Polytechnic University. Paul lives in southern California with his wife Linda. They have two adult children, Erika and Brett, who has severe hemophilia A.